Trisalus Life Sciences, Inc.
TLSI
Revenue
11.57M
▲353.00k▲3.15%
3 Months ChangeAssets
36.46M
▼-4.85M▼-11.75%
3 Months ChangeLiabilities
63.19M
▲2.45M▲4.03%
3 Months ChangeFree Cash Flow
-5.25M
▲5.68M▲51.95%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-11-01
Form 8-K
ID: 0001104659-24-113486
2024-08-15
Form 8-K
ID: 0001104659-24-089936
2024-08-14
Form 10-Q
ID: 0001826667-24-000039
2024-07-01
Form 8-K
ID: 0001104659-24-076841
2024-06-27
Form 8-K
ID: 0001104659-24-075234
2024-05-24
Form 8-K
ID: 0001104659-24-064883
2024-05-15
Form 10-Q
ID: 0001826667-24-000017
2024-05-15
Form 8-K
ID: 0001104659-24-061631
2024-05-07
Form 8-K
ID: 0001104659-24-057985
2024-04-30
Form 8-K
ID: 0001104659-24-055007